Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
high mobility group nucleosome binding domain 1 pseudogene 20 (HMGN1P20) is a human pseudogene with sequence similarity to the functional HMGN1 gene, which encodes a DNA-binding protein involved in chromatin structure and gene regulation. Pseudogenes are generally non-protein coding due to mutations and genomic rearrangements, but some can act as regulatory non-coding RNAs. No evidence indicates protein translation or direct biological function or disease association for HMGN1P20. The gene is annotated in genomic databases, but minimal research characterizes its expression, function, or involvement in pathology. HMGN1P20 is best classified as a processed pseudogene from the HMGN1 family. It is not recognized as a therapeutic target, lacks clear biological and disease associations, and is primarily annotated for its genomic sequence similarity. There are significant gaps and limitations in available information.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on high mobility group nucleosome binding domain 1 pseudogene 20 (HMGN1P20).